Yongzheng Biopharma & Rivocean Jiangsu Pharma: two pharmaceutical-related projects

Summary: The EI report of Yongzheng Biopharma's N-(4-Aminobenzoyl)-L-glutamic acid pharmaceutical intermediate project (Phase I) has entered approval process since late Feb. The EI report of Rivocean Jiangsu Pharma's upgrading and renovation project ...

Amino Acids China E-News 202303

www.cnchemicals.com